SCHEMBL159755

SCHEMBL159755

Cc1ccc(N=C=Nc2ccc(C)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.47
TDP1 Q9NUW8 2/20 0.47
HTR3E A5X5Y0 2/20 0.44
HTR3B O95264 2/20 0.44
HTR3A P46098 2/20 0.44
HTR3D Q70Z44 2/20 0.44
HTR3C Q8WXA8 2/20 0.44
SLC22A2 O15244 1/20 0.44
SLC22A1 O15245 1/20 0.44
SLC22A3 O75751 1/20 0.44
PLAU P00749 1/20 0.44
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 2/20 0.38
STAT3 P40763 1/20 0.38
STAT1 P42224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27972070 0.84 ACHE (0.62) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL287022 0.82 TSHR (0.43) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL15086591 0.81 HTR3E (0.35) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL25895328 0.81 HTR3E (0.35) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL18245040 0.81 NOS3 (0.36) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL11430813 0.81 HTR3E (0.40) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL332260 0.78 MIF (0.56) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL1011250 0.78 ACHE (0.42) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL8740945 0.78 ACHE (0.42) ACHETDP1HTR3EHTR3BHTR3A
SCHEMBL9887642 0.78 ACHE (0.42) ACHETDP1HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026055875-A9 ONE-COMPONENT (1K) HEAT-ACTIVATABLE WATERBORNE POLYURETHANE ADHESIVE AND USE THEREOF HENKEL AG & CO. KGAA (DE) 2026-05-15 WO claimed
US-20260108615-A1 SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF UNIV SZEGEDI (HU) 2026-04-23 US claimed
US-20260066464-A1 BATTERY SUBSTRATE FOR SEPARATING POSITIVE ELECTRODE AND NEGATIVE ELECTRODE FROM EACH OTHER IN RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY COMPRISING SAME SAMSUNG SDI CO LTD (KR) 2026-03-05 US claimed
US-20250332824-A1 ADHESIVE BACKED HYDROLYSIS-RESISTANT WINDOW FILM GARWARE HI-TECH FILMS LIMITED (IN) 2025-10-30 US claimed
EP-4408474-A1 SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF Szegedi Tudományegyetem (HU) 2024-08-07 EP claimed
CN-118431473-A Binder composition, slurry composition, electrode, and secondary battery 上海百公里新材料科技有限公司 2024-08-02 CN claimed
US-11718576-B2 Compositions and methods comprising resveratrol BIOCOGENT, LLC (US) 2023-08-08 US claimed
CN-114988401-B Method for directly blackening graphene oxide modified by PCB 南通赛可特电子有限公司 2023-06-09 CN claimed
WO-2023052799-A1 SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF Szegedi Tudományegyetem (HU) 2023-04-06 WO claimed
CN-115850324-A Method for synthesizing choline phospholipide based on esterification reaction 于喜飞 2023-03-28 CN claimed
US-20060122078-A1 prevent lead leaching in lead-containing automatic transmissions, using transmission fluid oil comprising caprylic acid, and bis-(2,6-diisopropylphenyl)-carbodiimide; corrosion inhibition, improved lubricity, and improved lead compatibility AFTON CHEMICAL CORPORATION 2006-06-08 US claimed
US-20060122077-A1 Compositions comprising at least one carbodiimide AFTON CHEMICAL CORPORATION 2006-06-08 US claimed
US-6883587-B2 Polyisocyanate compositions and their use ASHLAND INC. (US) 2005-04-26 US claimed
US-20030173055-A1 Polyisocyanate compositions and their use ASK Chemicals LLC 2003-09-18 US claimed
EP-1089769-A1 CARBODIIMIDE CROSS-LINKED ALBUMIN FOR BIOADHESIVES, SURGICAL SEALANTS AND IMPLANTABLE DEVICES Surgical Sealants, Incorporated (US) 2001-04-11 EP claimed
WO-1999066964-A1 CARBODIIMIDE CROSS-LINKED ALBUMIN FOR BIOADHESIVES, SURGICAL SEALANTS AND IMPLANTABLE DEVICES SURGICAL SEALANTS, INCORPORATED (US) 1999-12-29 WO claimed
US-5965739-A OXAZOLIDINE PROTECTED TAXOL ANALOGS OF GIVEN FORMULA, AND METHODS OF SYNTHESIS FROM AN OXAZOLIDINE FREE ACID AND A BACCATIN COMPOUND IN THE PRESENCE OF A DEHYDRATING AGENT; USEFUL INTERMEDIATES TO MAKE VARIOUS TAXOL ANALOGUES PHARMACIA & UPJOHN COMPANY (US) 1999-10-12 US claimed
EP-0088642-A2 New camptothecin derivatives and process for their preparation KABUSHIKI KAISHA YAKULT HONSHA (JP) 1983-09-14 EP claimed
US-4012464-A S-(2-diisopropylamino-ethyl)O-ethyl methylphosphonothioate stabilized with soluble carbodiimides THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1977-03-15 US claimed
US-4008270-A Process for preparing 2-(substituted phenyl)propionic acids THE UPJOHN COMPANY (US) 1977-02-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260108615-A1 SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF MUC1, FIBP, PTMS ACHE 3857/4885TDP1 4709/4885HTR3E 3393/4885
US-20260066464-A1 BATTERY SUBSTRATE FOR SEPARATING POSITIVE ELECTRODE AND NEGATIVE ELECTRODE FROM EACH OTHER IN RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY COMPRISING SAME HSPB1, HSPA1B, HSPBP1 ACHE 132/4885TDP1 1125/4885HTR3E 1379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.